Metabolic profiles predict adverse events after coronary artery bypass grafting

Journal of Thoracic and Cardiovascular Surgery

Volumn 143, Issue 4, 2012, Pages 873-878

  Shah, Asad A ^a   Craig, Damian M ^a   Sebek, Jacqueline K ^a   Haynes, Carol ^a   Stevens, Robert C ^a   Muehlbauer, Michael J ^a   Granger, Christopher B ^a   Hauser, Elizabeth R ^a   Newby, L Kristin ^a   Newgard, Christopher B ^a   Kraus, William E ^a   Hughes, G Chad ^a   Shah, Svati H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; KETONE;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HAZARD RATIO; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLITE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PLASMA; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK; UNIVARIATE ANALYSIS;

AGED; BIOLOGICAL MARKERS; CARNITINE; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; ENERGY METABOLISM; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KETONES; MALE; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NORTH CAROLINA; ODDS RATIO; PRINCIPAL COMPONENT ANALYSIS; PROPORTIONAL HAZARDS MODELS; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84858339934     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.09.070     Document Type: Article

References (21)

1. T. Kimura, T. Morimoto, Y. Furukawa, Y. Nakagawa, S. Shizuta, and N. Ehara Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era Circulation 118 14 Suppl 2008 S199 S209
2. D.M. Cosgrove, F.D. Loop, B.W. Lytle, C.C. Gill, L.A. Golding, and C. Gibson Predictors of reoperation after myocardial revascularization J Thorac Cardiovasc Surg 92 1986 811 821
3. P.T. Sergeant, E.H. Blackstone, and B.P. Meyns Does arterial revascularization decrease the risk of infarction after coronary artery bypass grafting? Ann Thorac Surg 66 1998 1 11
4. P. Peduzzi, K. Detre, M.L. Murphy, J. Thomsen, H. Hultgren, and T. Takaro Ten-year incidence of myocardial infarction and prognosis after infarction. Department of Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery Circulation 83 1991 747 755
5. S.A. Nashef, F. Roques, P. Michel, E. Gauducheau, S. Lemeshow, and R. Salamon European System for Cardiac Operative Risk Evaluation (EuroSCORE) Eur J Cardiothorac Surg 16 1999 9 13
6. K. Suhre, C. Meisinger, A. Döring, E. Altmaier, P. Belcredi, and C. Gieger Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting PLoS One 5 2010 e1395
7. S.H. Shah, J.R. Bain, M.J. Muehlbauer, R.D. Stevens, D.R. Crosslin, and C. Haynes Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events Circ Cardiovasc Genet 3 2010 207 214
8. S.H. Shah, C.B. Granger, E.R. Hauser, W.E. Kraus, J.L. Sun, and K. Pieper Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study Am Heart J 160 2010 371 379.e2 -
9. J. An, D.M. Muoio, M. Shiota, Y. Fujimoto, G.W. Cline, and G.I. Shulman Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance Nat Med 10 2004 268 274
10. C.B. Newgard, J. An, J.R. Bain, M.J. Muehlbauer, R.D. Stevens, and L.F. Lien A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance Cell Metab 9 2009 311 326 erratum in Cell Metab. 2009;9:565-6
11. D.H. Chace, S.L. Hillman, D.S. Millington, S.G. Kahler, C.R. Roe, and E.W. Naylor Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry Clin Chem 41 1995 62 68
12. S.H. Shah, E.R. Hauser, J.R. Bain, M.J. Muehlbauer, C. Haynes, and R.D. Stevens High heritability of metabolomic profiles in families burdened with premature cardiovascular disease Mol Syst Biol 5 2009 258
13. H.F. Kaiser The application of electronic computers to factor analysis Educ Psychol Meas 20 1960 141 151
14. S.H. Shah, J.L. Sun, K. Pieper, D.R. Crosslin, C. Haynes, and J.R. Bain Plasma metabolic profiles predict future cardiovascular events Circulation 120 2009 S466 S467
15. S. Ferdinandusse, S. Denis, C.W. Van Roermund, R.J. Wanders, and G. Dacremont Identification of the peroxisomal beta-oxidation enzymes involved in the degradation of long-chain dicarboxylic acids J Lipid Res 45 2004 1104 1111
16. D.W. Johnson Synthesis of dicarboxylic acylcarnitines Chem Phys Lipids 129 2004 161 171
17. A. Pelletier, and L. Coderre Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes Am J Physiol Endocrinol Metab 292 2007 E1325 E1332
18. C. Depre, J.L.J. Vanoverschelde, and H. Taegtmeyer Glucose for the heart Circulation 99 1999 578 588
19. S. Abdel-Aleem, J.D. St Louis, G.C. Hughes, and J.E. Lowe Metabolic changes in the normal and hypoxic neonatal myocardium Ann N Y Acad Sci 874 1999 254 261
20. J. Lommi, M. Kupari, P. Koskinen, H. Naveri, H. Leinonen, and K. Pulkki Blood ketone bodies in congestive heart failure J Am Coll Cardiol 28 1996 665 672
21. T. Illig, C. Gieger, G. Zhai, W. Römisch-Margl, R. Wang-Sattler, and C. Prehn A genome-wide perspective of genetic variation in human metabolism Nat Genet 42 2010 137 141